Project Grant 2123277

Award Date 2/15/21
Completion Date 11/30/21
Dollars Obligated $304K
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
West Menlo Park, CA 94025, USA
Similar Awards
The National Science Foundation (NSF), under its Engineering program (CFDA 47.041), awarded a $429,832 Project Grant to the University of Massachusetts (UMass) to develop a novel method for rapid and sensitive detection of nucleic acids such as DNA and RNA. The main objectives of the 5-year project are to: Determine the nanomechanoelectrical transduction principle of nucleic-acid nanostructures tethered to a graphene transistor and oscillating in an electric field. Achieve rapid,...
This $960,000 National Science Foundation project grant supports the development of a multiplexed plasmon-enhanced lateral flow assay for point-of-care detection of SARS-CoV-2 RNA and antigens. Funded under the NSF Engineering program (CFDA 47.041), the grantee, Washington University, will design, validate and build a novel diagnostic platform with sensitivity exceeding standard laboratory tests. Key deliverables include an ultrasensitive multiplexed lateral flow assay for simultaneous...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) is focused on developing an affordable, portable virus detection platform. The $331,189 project, awarded on April 1, 2025 and running through March 31, 2028, integrates protein engineering and electrochemical biosensor technologies to create a virus detection system that can operate in resource-limited environments. The innovation lies in using stable...
The National Science Foundation awarded a $220,000 Project Grant to the University of Connecticut under the Engineering (47.041) federal grant program. The award will fund development of a compact, field-portable biophotonics instrument for automated analysis and identification of blood cells impacted by COVID-19. The instrument aims to provide real-time sensing and diagnosis capabilities with high accuracy, specificity and sensitivity for potential early detection of COVID-19 infections. It...
The National Science Foundation awarded a $131,245 project grant to the University of Houston System under the Engineering federal grant program (CFDA 47.041) for development of a magnetoelectric biosensor for rapid point-of-care COVID-19 diagnostics. The University of Houston, as awardee, will utilize the February 2021 funding through the expected January 2023 completion date to create a magnetoelectric biosensor that can quickly detect the presence of COVID-19 at the point of care. The...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Quarksen LLC provides funding to develop an affordable, point-of-care diagnostic device for detecting viral and non-viral sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, HIV, hepatitis C, and trichomoniasis. The project aims to create a device with an array of sensors that can rapidly and accurately detect STI biomarkers from cervical...
This Project Grant from the National Science Foundation's Engineering Directorate (NSF ENG) provides $249,829 to Northeastern University to develop an integrated platform for high accuracy measurements of viral particle count and infectious titer. The platform will combine nano-pore technology to identify viral particles based on biophysical properties with single-molecule RNA fluorescence in situ hybridization to discriminate individual molecules of viral RNA in infected cells. This will enable...
The National Science Foundation awarded a $294,100 project grant to the University of Kansas Medical Center Research Institute, Inc. to support research titled "EAGER: ENGINEERING OPTICAL NANOBIOSENSORS FOR DETECTION OF CORONAVIRUS PROTEASES" under the NSF Engineering program (CFDA 47.041). The grant funding will support the development of optical nanobiosensors for detecting coronavirus proteases from March 15, 2021 through October 31, 2022. The NSF Directorate for Engineering seeks...
This $274,362 Project Grant awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports the development of a novel molecular diagnostic platform for detecting respiratory diseases, including strep throat, without the need for an expensive table-top device. The platform aims to provide the accuracy of laboratory-based tests for use by non-healthcare professionals in non-clinical settings, enabling rapid and reliable...
Purdue University received a $409,155 Project Grant award from the National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems on May 1, 2021 to develop rapid and ultrasensitive critical care testing at the point of need using multiplexed transient-state digital assays. The award is part of NSF's Engineering program (CFDA 47.041) and will support research to improve the quality of life and economic strength of the nation by fostering innovation in...

Numentus Technologies Inc. received a $303,685 Project Grant award from the National Science Foundation on February 15, 2021 to develop rapid planar PCR technology for COVID-19 testing. The award was made under the NSF's Engineering program (CFDA 47.041) to support innovation and excellence in engineering research.

Through this funding, Numentus will work to advance the development of planar PCR, a technology that enables highly sensitive COVID-19 detection on a single integrated testing platform. The aim is to deliver a fast, easy-to-use, and affordable testing solution to help curb the spread of the virus. Project activities under the nine-month award period include further optimizing the technology and validating its performance compared to established COVID-19 testing methods. Outcomes will support the NSF's goal of improving public health through engineering-driven solutions.

Generated 1/6/24, 1:11 PM